Nifty
Sensex
:
:
15778.45
52653.07
69.05 (0.44%)
209.36 (0.40%)

Pharmaceuticals & Drugs - Global

Rating :
56/99

BSE: 524804 | NSE: AUROPHARMA

908.25
29-Jul-2021
  • Open
  • High
  • Low
  • Previous Close
  •  920.00
  •  923.10
  •  905.05
  •  915.10
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  1240670
  •  11304.23
  •  1063.90
  •  738.05

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 53,214.94
  • 9.97
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 55,934.76
  • 0.33%
  • 2.43

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 51.83%
  • 0.69%
  • 8.54%
  • FII
  • DII
  • Others
  • 23.7%
  • 14.59%
  • 0.65%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 18.09
  • 10.86
  • 11.95

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 17.58
  • 8.82
  • 5.22

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 17.58
  • 7.06
  • 5.55

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 17.03
  • 16.21
  • 15.53

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 4.26
  • 3.29
  • 2.71

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 11.93
  • 10.84
  • 10.17

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 21
Mar 20
Var%
Dec 20
Dec 19
Var%
Sep 20
Sep 19
Var%
Jun 20
Jun 19
Var%
Net Sales
6,001.50
6,158.43
-2.55%
6,364.91
5,895.00
7.97%
6,483.44
5,600.47
15.77%
5,924.78
5,444.60
8.82%
Expenses
4,726.83
4,842.21
-2.38%
4,996.33
4,686.96
6.60%
5,050.63
4,460.25
13.24%
4,667.43
4,298.20
8.59%
EBITDA
1,274.67
1,316.22
-3.16%
1,368.58
1,208.04
13.29%
1,432.81
1,140.22
25.66%
1,257.35
1,146.40
9.68%
EBIDTM
21.24%
21.37%
21.50%
20.49%
22.10%
20.36%
21.22%
21.06%
Other Income
78.10
32.59
139.64%
133.40
30.93
331.30%
53.75
20.62
160.67%
115.59
15.78
632.51%
Interest
18.22
31.83
-42.76%
19.49
37.11
-47.48%
15.71
40.94
-61.63%
21.07
49.89
-57.77%
Depreciation
266.00
232.41
14.45%
276.52
250.13
10.55%
257.34
243.31
5.77%
255.52
240.86
6.09%
PBT
1,069.24
1,096.82
-2.51%
4,019.86
938.81
328.19%
1,213.51
863.83
40.48%
1,096.35
858.73
27.67%
Tax
259.69
214.35
21.15%
1,059.08
232.86
354.81%
387.33
224.37
72.63%
303.67
227.76
33.33%
PAT
809.55
882.47
-8.26%
2,960.78
705.95
319.40%
826.18
639.46
29.20%
792.68
630.97
25.63%
PATM
13.49%
14.33%
46.52%
11.98%
12.74%
11.42%
13.38%
11.59%
EPS
13.68
14.75
-7.25%
50.29
12.04
317.69%
13.76
10.92
26.01%
13.32
10.85
22.76%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Net Sales
24,774.63
23,098.51
19,563.55
16,463.03
14,909.54
13,794.65
12,120.52
8,099.79
5,855.32
4,627.40
4,381.48
Net Sales Growth
7.26%
18.07%
18.83%
10.42%
8.08%
13.81%
49.64%
38.33%
26.54%
5.61%
 
Cost Of Goods Sold
9,902.48
8,720.74
7,886.32
6,085.55
5,911.00
5,612.30
5,099.89
3,275.54
2,730.00
2,303.99
1,963.83
Gross Profit
14,872.15
14,377.77
11,677.23
10,377.48
8,998.54
8,182.35
7,020.63
4,824.25
3,125.32
2,323.41
2,417.65
GP Margin
60.03%
62.25%
59.69%
63.04%
60.35%
59.32%
57.92%
59.56%
53.38%
50.21%
55.18%
Total Expenditure
19,441.22
18,234.20
15,611.61
12,691.28
11,475.26
10,606.53
9,556.90
5,966.14
4,994.37
4,066.10
3,418.22
Power & Fuel Cost
-
587.68
556.79
470.95
437.14
419.26
359.60
349.84
324.72
232.36
208.26
% Of Sales
-
2.54%
2.85%
2.86%
2.93%
3.04%
2.97%
4.32%
5.55%
5.02%
4.75%
Employee Cost
-
3,219.18
2,584.87
2,130.84
1,767.76
1,542.62
1,302.26
802.43
663.31
535.69
425.07
% Of Sales
-
13.94%
13.21%
12.94%
11.86%
11.18%
10.74%
9.91%
11.33%
11.58%
9.70%
Manufacturing Exp.
-
2,331.41
2,037.95
1,611.12
1,309.64
1,256.18
1,022.70
772.04
623.04
543.16
511.60
% Of Sales
-
10.09%
10.42%
9.79%
8.78%
9.11%
8.44%
9.53%
10.64%
11.74%
11.68%
General & Admin Exp.
-
1,320.69
1,006.68
1,068.22
997.32
686.38
666.38
283.49
197.83
130.74
120.34
% Of Sales
-
5.72%
5.15%
6.49%
6.69%
4.98%
5.50%
3.50%
3.38%
2.83%
2.75%
Selling & Distn. Exp.
-
1,524.75
1,125.76
1,025.85
848.43
877.14
878.98
359.60
305.98
208.20
141.59
% Of Sales
-
6.60%
5.75%
6.23%
5.69%
6.36%
7.25%
4.44%
5.23%
4.50%
3.23%
Miscellaneous Exp.
-
529.75
413.24
298.75
203.97
212.65
227.09
123.20
149.49
111.96
141.59
% Of Sales
-
2.29%
2.11%
1.81%
1.37%
1.54%
1.87%
1.52%
2.55%
2.42%
1.08%
EBITDA
5,333.41
4,864.31
3,951.94
3,771.75
3,434.28
3,188.12
2,563.62
2,133.65
860.95
561.30
963.26
EBITDA Margin
21.53%
21.06%
20.20%
22.91%
23.03%
23.11%
21.15%
26.34%
14.70%
12.13%
21.98%
Other Income
380.84
191.87
155.32
101.98
115.89
203.80
96.71
21.56
28.54
24.70
71.41
Interest
74.49
305.13
262.60
77.72
66.72
256.70
159.87
310.16
266.64
277.24
64.65
Depreciation
1,055.38
966.71
667.95
557.97
427.63
392.37
332.61
312.53
248.74
200.53
171.50
PBT
7,398.96
3,784.34
3,176.71
3,238.04
3,055.82
2,742.85
2,167.85
1,532.52
374.11
108.23
798.52
Tax
2,009.77
913.52
726.85
818.27
759.65
720.71
596.59
363.45
82.71
-88.81
225.12
Tax Rate
27.16%
24.31%
23.53%
25.27%
24.86%
26.28%
27.52%
23.72%
22.11%
41.70%
28.56%
PAT
5,389.19
2,846.14
2,362.03
2,420.03
2,296.64
2,023.64
1,575.77
1,172.85
293.86
-123.50
563.45
PAT before Minority Interest
5,390.21
2,844.69
2,361.80
2,419.77
2,296.17
2,022.14
1,571.26
1,169.07
291.40
-124.14
563.06
Minority Interest
1.02
1.45
0.23
0.26
0.47
1.50
4.51
3.78
2.46
0.64
0.39
PAT Margin
21.75%
12.32%
12.07%
14.70%
15.40%
14.67%
13.00%
14.48%
5.02%
-2.67%
12.86%
PAT Growth
88.51%
20.50%
-2.40%
5.37%
13.49%
28.42%
34.35%
299.12%
-
-
 
EPS
91.98
48.58
40.31
41.30
39.20
34.54
26.89
20.02
5.02
-2.11
9.62

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Shareholder's Funds
16,810.38
13,890.78
11,680.42
9,371.91
7,287.30
5,155.91
3,750.15
2,605.76
2,339.65
2,444.83
Share Capital
58.59
58.59
58.59
58.59
58.52
29.20
29.15
29.12
29.11
29.11
Total Reserves
16,751.79
13,832.13
11,621.76
9,313.22
7,227.50
5,126.71
3,721.00
2,576.64
2,310.54
2,415.72
Non-Current Liabilities
565.88
358.13
594.11
102.07
583.85
1,591.60
1,493.91
1,225.26
967.29
645.49
Secured Loans
0.00
48.88
451.20
177.59
380.10
773.54
1,101.31
1,084.11
862.08
449.74
Unsecured Loans
0.00
131.07
0.00
3.81
362.71
587.93
178.05
64.15
102.55
73.61
Long Term Provisions
74.71
46.54
55.86
39.13
23.36
24.35
9.18
9.00
4.24
3.09
Current Liabilities
11,386.75
12,020.57
8,665.89
6,605.60
7,840.22
6,136.40
4,220.04
3,430.83
2,915.05
2,768.49
Trade Payables
2,545.01
2,552.18
2,372.90
2,154.70
2,457.03
2,051.13
1,351.20
963.75
660.14
776.35
Other Current Liabilities
2,874.56
2,510.51
1,967.42
1,286.82
1,577.58
1,364.95
387.68
150.87
580.34
699.09
Short Term Borrowings
5,422.30
6,573.21
4,031.34
2,902.72
3,672.68
2,502.08
2,354.56
2,236.12
1,608.21
1,234.73
Short Term Provisions
544.88
384.67
294.23
261.36
132.93
218.24
126.60
80.09
66.36
58.32
Total Liabilities
28,763.15
26,271.07
20,942.24
16,081.66
15,713.92
12,909.73
9,489.77
7,272.85
6,232.20
5,867.93
Net Block
9,396.47
8,474.85
6,520.68
4,833.78
4,179.69
3,705.64
2,721.67
2,638.87
2,194.65
1,738.60
Gross Block
12,441.26
10,497.62
7,894.78
5,635.49
4,569.83
5,446.13
4,182.96
3,763.47
3,086.25
2,438.00
Accumulated Depreciation
3,044.79
2,022.77
1,374.10
801.71
390.14
1,740.49
1,461.29
1,124.60
891.60
699.40
Non Current Assets
12,350.65
10,938.77
8,764.08
6,875.48
5,419.57
4,610.93
3,858.59
3,136.10
2,968.16
2,546.75
Capital Work in Progress
1,985.94
1,668.46
1,583.04
1,458.08
848.14
370.35
256.67
167.82
515.74
582.86
Non Current Investment
554.69
360.20
311.52
245.85
122.94
0.14
19.76
22.24
19.86
38.49
Long Term Loans & Adv.
376.94
396.64
261.91
256.48
236.56
455.27
789.04
237.82
108.12
110.77
Other Non Current Assets
36.61
38.62
86.93
81.29
32.24
30.25
18.40
18.66
0.12
1.47
Current Assets
16,412.50
15,332.30
12,178.16
9,206.18
10,294.35
8,298.80
5,631.18
4,136.75
3,264.04
3,321.18
Current Investments
0.02
0.02
0.02
0.02
0.02
19.65
0.03
0.04
18.68
0.04
Inventories
7,699.87
7,245.60
5,858.41
4,330.54
4,056.14
3,611.30
2,367.54
1,923.59
1,545.56
1,455.27
Sundry Debtors
4,315.15
3,413.78
3,080.20
2,765.33
4,606.68
3,539.17
2,636.57
1,596.98
1,239.96
1,230.98
Cash & Bank
2,842.15
1,957.18
1,262.25
513.48
800.26
469.11
178.58
208.45
70.86
186.72
Other Current Assets
1,555.31
1,919.82
1,223.32
1,084.72
831.25
659.57
448.46
407.69
388.98
448.17
Short Term Loans & Adv.
1,065.96
795.90
753.96
512.09
366.88
387.90
237.22
207.51
216.67
358.87
Net Current Assets
5,025.75
3,311.73
3,512.27
2,600.58
2,454.13
2,162.40
1,411.14
705.92
348.99
552.69
Total Assets
28,763.15
26,271.07
20,942.24
16,081.66
15,713.92
12,909.73
9,489.77
7,272.85
6,232.20
5,867.93

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Cash From Operating Activity
4,381.28
1,650.97
1,954.52
3,278.58
1,419.76
1,236.81
646.28
274.87
326.25
335.11
PBT
3,743.04
3,091.35
3,241.18
3,060.84
2,744.30
2,167.85
1,532.52
374.11
108.23
798.52
Adjustment
1,091.17
813.95
535.02
408.92
487.50
406.28
515.12
441.54
387.22
197.72
Changes in Working Capital
276.87
-1,484.50
-1,123.12
582.52
-1,079.41
-841.73
-1,057.41
-421.56
-128.34
-469.45
Cash after chg. in Working capital
5,111.08
2,420.80
2,653.08
4,052.28
2,152.39
1,732.40
990.23
394.09
367.11
526.79
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-729.80
-769.83
-698.56
-773.70
-732.63
-495.59
-343.95
-119.22
-40.86
-191.68
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-1,567.64
-2,902.59
-1,926.59
-1,787.04
-1,445.21
-1,397.97
-818.74
-246.34
-563.16
-599.07
Net Fixed Assets
-606.64
-799.00
-771.00
-1,092.24
125.11
-533.87
-141.02
-224.46
-376.05
-396.28
Net Investments
-180.64
-371.56
-285.55
-498.60
-170.60
-140.13
-164.64
-78.98
-135.92
-122.17
Others
-780.36
-1,732.03
-870.04
-196.20
-1,399.72
-723.97
-513.08
57.10
-51.19
-80.62
Cash from Financing Activity
-1,947.18
1,919.06
864.15
-1,915.26
365.44
93.21
117.64
108.09
118.85
406.98
Net Cash Inflow / Outflow
866.46
667.44
892.08
-423.72
339.99
-67.95
-54.82
136.62
-118.06
143.02
Opening Cash & Equivalents
1,875.58
1,209.94
318.03
743.49
403.81
148.02
202.73
65.64
183.71
44.72
Closing Cash & Equivalent
2,746.82
1,875.58
1,209.94
319.63
743.50
461.10
148.02
202.73
65.64
183.71

Financial Ratios

Consolidated /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Book Value (Rs.)
286.92
237.08
199.36
159.96
124.50
88.29
64.33
44.74
40.19
41.99
ROA
10.34%
10.00%
13.07%
14.44%
14.13%
14.03%
13.95%
4.32%
-2.05%
10.57%
ROE
18.53%
18.47%
22.99%
27.57%
32.51%
35.29%
36.79%
11.78%
-5.19%
26.35%
ROCE
18.80%
17.97%
22.72%
24.92%
27.35%
27.18%
27.18%
11.17%
1.25%
19.29%
Fixed Asset Turnover
4.12
4.36
2.44
2.96
2.79
2.55
2.08
1.75
1.71
1.85
Receivable days
29.85
29.56
64.66
89.16
106.53
91.84
93.55
86.28
95.44
89.07
Inventory Days
57.72
59.64
112.70
101.43
100.27
88.91
94.82
105.51
115.91
104.17
Payable days
52.98
58.56
67.77
75.73
81.70
67.49
71.06
57.79
64.70
70.79
Cash Conversion Cycle
34.59
30.63
109.58
114.86
125.10
113.25
117.31
134.00
146.65
122.45
Total Debt/Equity
0.33
0.50
0.41
0.36
0.69
0.86
1.01
1.32
1.32
0.99
Interest Cover
13.32
12.76
42.66
46.80
11.69
14.56
5.94
2.40
0.23
13.19

News Update:


  • Aurobindo Pharma reports 7% fall in Q4 consolidated net profit
    31st May 2021, 15:00 PM

    The company has reported a standalone net profit of Rs 872.58 crore for the quarter ended March 31, 2021

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.